Skip to main content
NeuronFeed

Genesis Therapeutics vs immunitoAI

Which Drug Discovery AI tool is better in 2026?

Genesis Therapeutics

AI drug-discovery company building generative and predictive models to design small-molecule

$344M

immunitoAI

Bengaluru-based biotech building an AI platform that designs novel antibody therapeutics from

$6.1M

Side-by-side

Verdict

Genesis Therapeutics is the more established option (raised $344M); pricing is comparable on both sides.

Metric Genesis Therapeutics immunitoAI
Taglinei AI drug-discovery company building generative and predictive models to design small-molecule Bengaluru-based biotech building an AI platform that designs novel antibody therapeutics from
Foundedi 2020🏆
HQi
Employeesi 11-50 11-50
Neuron scorei 72🏆 45
Total fundingi $344M🏆 $6.1M
Latest roundi Strategic equity investment · May 2026 Series A
Valuationi
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Genesis Therapeutics and immunitoAI.

Capability Genesis Therapeutics immunitoAI
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Genesis Therapeutics

  • Has raised more capital ($344M vs $6.1M)
  • Higher Neuron score (72 vs 45)

🔵 Strengths of immunitoAI

  • Newer company (2020)

Which should you choose?

Choose immunitoAI if price matters most — it starts at Free, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Genesis Therapeutics if you want the most established option — it has raised $344M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Genesis Therapeutics vs immunitoAI — which is better?

It depends on your priority. Genesis Therapeutics has raised more capital and is the more established option; immunitoAI has broader feature depth. See the side-by-side table above.

Is Genesis Therapeutics cheaper than immunitoAI?

No — immunitoAI's cheapest paid plan is Free, while Genesis Therapeutics's is Free.

Do Genesis Therapeutics and immunitoAI offer free plans?

Genesis Therapeutics: Yes, has a free plan. immunitoAI: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.